SEC Form D private-offering filing

Elucid Bioimaging Inc.

Name: Elucid Bioimaging Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2025-10-22

A new SEC Form D private-offering notice from Boston, MA, a $79,999,999 filer-stated offering target in Biotech. The source filing is one click away.

Elucid Bioimaging Inc. site↗ Verified via SEC Form D

Developer of Plaque IQ, an FDA cleared AI software that analyzes CT angiography scans to assess arterial plaque and cardiovascular risk

Filed 2025-10-22Filed to raise $79,999,999First money in 2025-10-10Raised so far $36,495,008HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified elucid.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.